Relapsed Follicular Lymphoma Active Not Recruiting Phase 1 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0041364 (Relapsed Follicular Lymphoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03806179Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FLTreatment